placeholder image

P. J. Flynn All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab. 
    NPJ breast cancer. 2021
    Article has an altmetric score of 5  
  • NSABP B-47/NRG Oncology Phase III randomized trial comparing adjuvant chemotherapy with or without trastuzumab in high-risk invasive breast cancer negative for HER2 by FISH and with IHC 1+ or 2. 
    Journal of Clinical Oncology. 2020
    Article has an altmetric score of 45  
  • Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG). 
    Journal of Neuro-Oncology. 2019
    Article has an altmetric score of 8
  • Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572. 
    Cancer. 2018
    Article has an altmetric score of 3
  • Randomized, multicenter, placebo-controlled clinical trial of duloxetine versus placebo for aromatase inhibitor-associated arthralgias in early-stage breast cancer: SWOG S1202. 
    Journal of Clinical Oncology. 2018
    Article has an altmetric score of 101  

    • Contact

    full name

  • P. J. Flynn

    • Quick Info

    Publications

    Collaboration